DIFFUSION PHARMACEUTICALS IN - COM PAR

CUSIP: 253748305

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / COM PAR
Total 13F shares
3,285,868
Share change
-170,366
Total reported value
$1,041,000
Price per share
$0.32
Number of holders
13
Value change
-$237,069
Number of buys
9
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 253748305?
CUSIP 253748305 identifies 253748305 - DIFFUSION PHARMACEUTICALS IN - COM PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of DIFFUSION PHARMACEUTICALS IN - COM PAR as of Q1 2020

As of 31 Mar 2020, DIFFUSION PHARMACEUTICALS IN - COM PAR was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,285,868 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, MILLENNIUM MANAGEMENT LLC, BANK OF AMERICA CORP /DE/, VANGUARD GROUP INC, Swift Run Capital Management, LLC, and Private Advisor Group, LLC. This page lists 13 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.